SABSW icon

SAB Biotherapeutics Warrant

10 hedge funds and large institutions have $88.4K invested in SAB Biotherapeutics Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

86% less call options, than puts

Call options by funds: $7K | Put options by funds: $49K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7K
Puts
$49K
Net Calls
Net Calls Change

Top Buyers

1 +$10
2 +$10

Top Sellers

1 -$18K
2 -$15.8K
3 -$1.62K
4
MC
Meteora Capital
Florida
-$1.28K
5
FTUS
Flow Traders U.S.
New York
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$56.3K
2
$15.5K
3
$11.3K
4
$2.43K
5
$1.62K
6
$977
7
$112
8
$10
9
$10
10
$5
11
12
13
14
15
16